SAVARA INC (SVRA) Fundamental Analysis & Valuation

NASDAQ:SVRA • US8051111016

5.315 USD
-0.21 (-3.89%)
Last: Mar 12, 2026, 03:36 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This SVRA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to SVRA. SVRA was compared to 519 industry peers in the Biotechnology industry. While SVRA seems to be doing ok healthwise, there are quite some concerns on its profitability. SVRA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. SVRA Profitability Analysis

1.1 Basic Checks

  • In the past year SVRA has reported negative net income.
  • SVRA had a negative operating cash flow in the past year.
  • In the past 5 years SVRA always reported negative net income.
  • SVRA had a negative operating cash flow in each of the past 5 years.
SVRA Yearly Net Income VS EBIT VS OCF VS FCFSVRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

  • SVRA has a worse Return On Assets (-82.03%) than 67.63% of its industry peers.
  • Looking at the Return On Equity, with a value of -122.48%, SVRA is in line with its industry, outperforming 40.46% of the companies in the same industry.
Industry RankSector Rank
ROA -82.03%
ROE -122.48%
ROIC N/A
ROA(3y)-34.4%
ROA(5y)-35.67%
ROE(3y)-43.45%
ROE(5y)-47.43%
ROIC(3y)N/A
ROIC(5y)N/A
SVRA Yearly ROA, ROE, ROICSVRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400

1.3 Margins

  • SVRA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SVRA Yearly Profit, Operating, Gross MarginsSVRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5K -10K -15K -20K -25K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. SVRA Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for SVRA has been increased compared to 1 year ago.
  • SVRA has more shares outstanding than it did 5 years ago.
  • SVRA has a better debt/assets ratio than last year.
SVRA Yearly Shares OutstandingSVRA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
SVRA Yearly Total Debt VS Total AssetsSVRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • An Altman-Z score of 6.90 indicates that SVRA is not in any danger for bankruptcy at the moment.
  • SVRA's Altman-Z score of 6.90 is fine compared to the rest of the industry. SVRA outperforms 75.53% of its industry peers.
  • SVRA has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
  • SVRA has a worse Debt to Equity ratio (0.32) than 67.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Altman-Z 6.9
ROIC/WACCN/A
WACCN/A
SVRA Yearly LT Debt VS Equity VS FCFSVRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 7.65 indicates that SVRA has no problem at all paying its short term obligations.
  • SVRA has a Current ratio of 7.65. This is in the better half of the industry: SVRA outperforms 71.48% of its industry peers.
  • SVRA has a Quick Ratio of 7.65. This indicates that SVRA is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Quick ratio value of 7.65, SVRA is doing good in the industry, outperforming 71.48% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.65
Quick Ratio 7.65
SVRA Yearly Current Assets VS Current LiabilitesSVRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. SVRA Growth Analysis

3.1 Past

  • The earnings per share for SVRA have decreased strongly by -23.26% in the last year.
EPS 1Y (TTM)-23.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27.27%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 26.20% on average over the next years. This is a very strong growth
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-11.87%
EPS Next 2Y2.08%
EPS Next 3Y16.08%
EPS Next 5Y26.2%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SVRA Yearly Revenue VS EstimatesSVRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2018 2020 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M
SVRA Yearly EPS VS EstimatesSVRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 -5 -10 -15

More info and screens

Find the best growth stocksShow best growing peers

0

4. SVRA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for SVRA. In the last year negative earnings were reported.
  • Also next year SVRA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SVRA Price Earnings VS Forward Price EarningsSVRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SVRA Per share dataSVRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4

4.3 Compensation for Growth

  • A more expensive valuation may be justified as SVRA's earnings are expected to grow with 16.08% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.08%
EPS Next 3Y16.08%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SVRA Dividend Analysis

5.1 Amount

  • SVRA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SVRA Fundamentals: All Metrics, Ratios and Statistics

SAVARA INC

NASDAQ:SVRA (3/12/2026, 3:36:07 PM)

5.315

-0.21 (-3.89%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-12
Earnings (Next)03-26
Inst Owners78.43%
Inst Owner Change19.17%
Ins Owners2.15%
Ins Owner Change-1.2%
Market Cap1.08B
Revenue(TTM)N/A
Net Income(TTM)-115.60M
Analysts85.71
Price Target11.03 (107.53%)
Short Float %11.8%
Short Ratio12.52
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.07%
Min EPS beat(2)-12.66%
Max EPS beat(2)-3.49%
EPS beat(4)1
Avg EPS beat(4)-5.53%
Min EPS beat(4)-14.48%
Max EPS beat(4)8.5%
EPS beat(8)3
Avg EPS beat(8)-3.35%
EPS beat(12)6
Avg EPS beat(12)-3.68%
EPS beat(16)8
Avg EPS beat(16)-0.68%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)4.85%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.07%
EPS NY rev (1m)0%
EPS NY rev (3m)0.24%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 11.46
P/tB 13.07
EV/EBITDA N/A
EPS(TTM)-0.53
EYN/A
EPS(NY)-0.45
Fwd EYN/A
FCF(TTM)-0.49
FCFYN/A
OCF(TTM)-0.49
OCFYN/A
SpS0
BVpS0.46
TBVpS0.41
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -82.03%
ROE -122.48%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-34.4%
ROA(5y)-35.67%
ROE(3y)-43.45%
ROE(5y)-47.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 15.63%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.65
Quick Ratio 7.65
Altman-Z 6.9
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)145.23%
Cap/Depr(5y)348.79%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-23.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27.27%
EPS Next Y-11.87%
EPS Next 2Y2.08%
EPS Next 3Y16.08%
EPS Next 5Y26.2%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-36.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year60.72%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-123.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-124.39%
OCF growth 3YN/A
OCF growth 5YN/A

SAVARA INC / SVRA FAQ

Can you provide the ChartMill fundamental rating for SAVARA INC?

ChartMill assigns a fundamental rating of 2 / 10 to SVRA.


What is the valuation status for SVRA stock?

ChartMill assigns a valuation rating of 0 / 10 to SAVARA INC (SVRA). This can be considered as Overvalued.


What is the profitability of SVRA stock?

SAVARA INC (SVRA) has a profitability rating of 0 / 10.


How financially healthy is SAVARA INC?

The financial health rating of SAVARA INC (SVRA) is 5 / 10.